Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Rare COVID reactions might hold key to variant-proof vaccines

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 592, 20-21 (2021)

doi: https://doi.org/10.1038/d41586-021-00722-8

References

  1. Moyo-Gwete, T. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.03.06.434193 (2021).

  2. Xie, X. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.01.07.425740 (2021).

  3. Cele, S. et al. Preprint at medRxiv https://doi.org/10.1101/2021.01.26.21250224 (2021).

  4. Shinde, V. et al. Preprint at medRxiv https://doi.org/10.1101/2021.02.25.21252477 (2021).

  5. Madhi, S. A. et al. New Eng. J. Med. https://doi.org/10.1056/NEJMoa2102214 (2021).

    PubMed  Google Scholar 

  6. Faulkner, N. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.03.01.433314 (2021).

  7. Muecksch, F. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.03.07.434227 (2021).

  8. Stamatatos, L. et al. Preprint at medRxiv https://doi.org/10.1101/2021.02.05.21251182 (2021).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links